期刊文献+

腔内治疗股腘动脉硬化性闭塞症的体会

Study on Transluminal Angioplasty in the Treatment of Patients with Lower Limb Atherosclerosis
下载PDF
导出
摘要 目的:评价经皮血管腔内成形术治疗下肢动脉硬化性闭塞症的价值。方法:21例TASCⅡC D型股动脉或腘动脉硬化性闭塞症患者,共26条下肢动脉硬化症行经皮血管腔内成形术,比较术前后患肢临床症状的变化。结果:22条肢体开通或部分开通,将肢体放置支架,1条肢体行股骨中段水平截肢,1条肢体行旁路转流术。随访1~6个月,多数患者肢体的临床症状有好转。结论:分段血管腔内成形术和膝下动脉行PTA后应用尿激酶对提高PTA的成功率和近期通畅率有帮助。 Objective: To evaluate the value of transluminal angioplasty in the treatment of lower limb atherosclerosis.Methods: Retrospectively analyzed the clinical change of 21 cases with trans-atlanticinter-society consensus Ⅱ(TASC Ⅱ) type C and D femoropopliteal arteriosclerosis obliterans patients,with a total of 26 lower limb,who accepted atherosclerosis percutaneous transluminal angioplasty.Results: A total of 22 limbs acquired recanalization or partially recanalization,including placement of stent in 2 cases,one limb amputation at the middle of femoral bone,and one case of bypass.In most cases,the clinical symptoms of limb improved in one to six monthes period of follow-up.Conclusions: Segmental transluminal angioplasty and application of urokinase after below-knee artery PTA are helpful to the success of operation and short-term patency.
出处 《中国临床医学》 2010年第5期707-708,共2页 Chinese Journal of Clinical Medicine
关键词 动脉硬化闭塞症 血管腔内成形术 Arteriosclerosis Transluminal angioplasty
  • 相关文献

参考文献3

  • 1Norgren L,Hiatt WR,Dormandy JA,et al.Inter-society consensus for the management of peripheral arterial disease(TASCⅡ)[J].J Vasc Endovase Surg,2007,45:5-67.
  • 2尹至,董智慧,符伟国.外周动脉疾病的治疗性血管生成[J].中国临床医学,2010,17(3):455-458. 被引量:3
  • 3Hirseh AT,Haskal ZJ,Hefizer NR,et al.ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterialdisease (10wer extrcmity;renal mesenteric and abdom final aortic)[J].Circulation,2006,13(11):463-654.

二级参考文献20

  • 1Hirsch AT,Haskal ZJ,Hertzer NR,et al.ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity,renal,mesenteric,and abdominal aortic):a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery,Society for Cardiovascular Angiography and Interventions,Society for Vascular Medicine and Biology,Society of Interventional Radiology,and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease):endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation;National Heart,Lung,and Blood Institute;Society for Vascular Nursing;TransAtlantic Inter-Society Consensus;and Vascular Disease Foundation[J].Circulation,2006,113(11):463-654.
  • 2The ICAI Study Group.Prostanoids for chronic critical leg ischemia.A rand omized,controlled,open-label trial with prostagland in E1.Ischemia Cronica degli Arti Inferiori[J].Ann Intern Med,1999,130(5):412-421.
  • 3Albers M,Fratezi AC,De Luccia N.Assessment of quality of life of patients with severe ischemia as a result of infrainguinal arterial occlusive disease[J].J Vasc Surg,1992,16(1):54-59.
  • 4Davies N,Dobner S,Bezuidenhout D,et al.The dosage dependence of VEGF stimulation on scaffold neovascularisation[J].Biomaterials,2008,29(26):3531-3538.
  • 5Adams RH,Alitalo K.Molecular regulation of angiogenesis and lymphangiogenesis[J].Nat Rev Mol Cell Biol,2007,8(6):464-478.
  • 6Simons M.Angiogenesis:where do we stand now[J] ? Circulation,2005,111(12):1556-1566.
  • 7Dellian M,Witwer BP,Salehi HA,et al.Quantitation and physiological characterization of angiogenic vessels in mice:effect of basic fibroblast growth factor,vascular endothelial growth factor/vascular permeability factor,and host microenvironment[J].Am J Pathol,1996,149(1):59-71.
  • 8Rajagopalan S,Olin J,Deitcher S,et al.Use of a constitutively active hypoxia-inducible factor-1alpha transgene as a therapeutic strategy in no-option critical limb ischemia patients:phase I dose-escalation experience[J].Circulation,2007,115(10):1234-1243.
  • 9Carmeliet P.VEGF gene therapy:stimulating angiogenesis or angioma-genesis[J] ? Nat Med,2000,6(10):1102-1103.
  • 10Marui A,Tabata Y,Kojima S,et al.A novel approach to therapeutic angiogenesis for patients with critical limb ischemia by sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogel:an initial report of the phase I-IIa study[J].Circ J,2007,71(8):1181-1186.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部